Frossard N, Frankhuyzen-Sierevogel J C, Binck M, Noordhoek J, Landry Y
Agents Actions. 1985 Apr;16(3-4):166-9. doi: 10.1007/BF01983129.
Clenbuterol 10(-8) to 10(-6) M inhibited antigen-induced histamine release from passively sensitized human lung tissue. This inhibition was not antagonized by propranolol, whereas the inhibitions observed with isoprenaline and fenoterol were reduced by propranolol. Clenbuterol also inhibited compound 48/80-induced histamine release and immunological histamine secretion from actively sensitized peritoneal rat mast cells. High concentrations of clenbuterol were required (10(-5) to 10(-3) M) and propranolol did not antagonize these inhibitions of histamine release. Isoprenaline and salbutamol did not modify the secretion from rat mast cells. The potential anti-anaphylactic activity of clenbuterol, might be partly related to its calcium antagonist property.
克仑特罗浓度为10⁻⁸至10⁻⁶M时,可抑制抗原诱导的被动致敏人肺组织中组胺的释放。普萘洛尔不能拮抗这种抑制作用,而异丙肾上腺素和非诺特罗所致的抑制作用则可被普萘洛尔减弱。克仑特罗还可抑制化合物48/80诱导的组胺释放以及主动致敏的大鼠腹膜肥大细胞的免疫性组胺分泌。这需要高浓度的克仑特罗(10⁻⁵至10⁻³M),且普萘洛尔不能拮抗这些对组胺释放的抑制作用。异丙肾上腺素和沙丁胺醇不影响大鼠肥大细胞的分泌。克仑特罗潜在的抗过敏活性可能部分与其钙拮抗特性有关。